Securities fraud litigation history and active cases
Active Cases
0
Pending Settlement
1
Closed
0
Total Settlement
$6.5M
Amylyx Pharmaceuticals, Inc. (AMLX) Class Action Lawsuit (February 2024)Pending Settlement
1:24cv12068 • February 9, 2024
Class Period Start
November 10, 2022
Class Period End
February 6, 2024
PSLRA Deadline
April 9, 2024
Case Allegations
10b5
Statutes of Repose
Nov 10, 2025
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
August 31, 2026
Settlement Fund
$6,500,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or otherwise acquired Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) securities during the period from November 11, 2022, through November 8, 2023, inclusive.
Claim Administrator
Strategic Claims Services
600 N. Jackson St., Suite 205
P.O. Box 230
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://www.strategicclaims.net/case/amylyx/Hearing Date
September 10, 2026
Opt-out Deadline
August 11, 2026
Settlement Note
Download hereProof Of Claim
Download here
Docket History
May 19, 2026
Preliminary Approval of Settlement
May 12, 2026
Notice of Pendency
May 12, 2026
Proof of Claim Form
May 4, 2026
Motion for Preliminary Approval of Settlement
Sep 30, 2025
Motion to Dismiss Denied
Sep 6, 2024
Motion to Dismiss
Jun 24, 2024
First Amended Complaint
Apr 17, 2024
Appointment of Lead Plaintiff
Feb 9, 2024
First Filed Complaint
TOP
